Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism.
Audrey DeprinceNathalie HennuyerSander KooijmanAmanda C M PronkEric BaugéViktor LienardAn VerrijkenEveline DirinckLuisa VonghiaEloïse WoitrainNiels J KloosterhuisEléonore MarezPauline JacquemainJustina Clarinda WoltersFanny LalloyerDelphine EberléSandrine QuemenerEmmanuelle VallezAnne TailleuxMostafa KouachJean-Francois GoossensVioleta RaverdyBruno DerudasJan Albert KuivenhovenMikaël CroyalBart van de SluisSven M FrancqueFrancois PattouPatrick C N RensenBart StaelsJoel T HaasPublished in: Hepatology (Baltimore, Md.) (2022)
These data reveal a previously undescribed role for ApoF in the control of plasma and hepatic lipoprotein metabolism by favoring VLDL-TG secretion and hepatic lipoprotein remnant particle clearance.